Pharmacological and Therapeutic Insights into Anticancer Drug Resistance
PDF

Keywords

Anticancer drug resistance
pharmacological mechanisms
drug efflux
apoptosis
combination therapy

Abstract

Anticancer drug resistance remains a significant challenge in cancer therapy, impeding the effectiveness of conventional chemotherapeutic agents. This resistance can occur through various mechanisms, including drug efflux, altered drug targets, and evasion of apoptosis. This article reviews the pharmacological mechanisms behind anticancer drug resistance, focusing on cellular and molecular pathways that facilitate resistance. It also discusses recent therapeutic strategies to overcome resistance, including combination therapies, molecular targeting, and immune modulation. Understanding the molecular underpinnings of drug resistance is crucial for the development of novel therapeutic interventions that can improve patient outcomes.

PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Dr. Sarah Ahmed (Author)